Editorial: Combination chemotherapy for breast cancer.
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use
D000277:Adjuvants, Pharmaceutic; D004317:Doxorubicin; D008558:Melphalan